Artemisinin selectively decreases functional levels of estrogen receptor-alpha and ablates estrogen-induced proliferation in human breast cancer cells

Carcinogenesis

Volumn 29, Issue 12, 2008, Pages 2252-2258

  Sundar, Shyam N ^a   Marconett, Crystal N ^a   Doan, Victor B ^a   Willoughby, Jamin A ^a   Firestone, Gary L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3,5 TRIS(4 HYDROXYPHENYL) 4 PROPYLPYRAZOLE; ARTEMISININ; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL STRAIN MCF 7; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ESTROGEN RESPONSIVE ELEMENT; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION;

ANTINEOPLASTIC AGENTS; ARTEMISININS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTOR MODULATORS; ESTROGENS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; IMMUNOPRECIPITATION; PROMOTER REGIONS, GENETIC; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 57349179869     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn214     Document Type: Article

References (37)

1. Draper,L. (2006) Breast cancer: Trends, risks, treatments, and effects. AAOHN J., 54, 445-453.
2. Kian Tee,M. et al. (2004) Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta. Mol. Biol. Cell, 15, 1262-1272.
3. Bocchinfuso,W.P. et al. (1997) Mammary gland development and tumorigenesis in estrogen receptor knockout mice, J. Mammary Gland Biol. Neoplasia, 2, 323-334.
4. Bocchinfuso,WP. et al. (2000) Induction of mammary gland development in estrogen receptor-alpha knockout mice. Endocrinology 141, 2982-2994.
5. Cordera,F. et al. (2006) Steroid receptors and their role in the biology and control of breast cancer growth. Semin. Oncol., 33 631-641.
6. Forster,C. et al. (2002) Involvement of estrogen receptor beta in terminal differentiation of mammary gland epithelium. Proc. Natl Acad. Sci. USA, 99, 15578-15583.
7. Frech,M.S. et al. (2005) Deregulated estrogen receptor alpha expression in mammary epithelial cells of transgenic mice results in the development of ductal carcinoma in situ. Cancer Res., 65, 681-685.
8. Hewitt,S.C. et al. (2002) Lack of ductal development in the absence of functional estrogen receptor alpha delays mammary tumor formation induced by trarnsgenic expression of ErbB2/neu. Cancer Res. 62, 2798-2805.
9. Lazennec,G. et al. (2001) ER beta inhibits proliferation and invasion of breast cancer cells. Endocrinology, 142, 4120-4130.
10. Saji,S. et al. (2001) Quantitative analysis of estrogen receptor proteins in rat mammary gland. Endocrinology, 142, 3177-3186.
11. Shyamala,G. et al. (2002) Cellular expression of estrogen and progesterone receptors in mammary glands: Regulation by hormones, development and aging. J. Steroid Biochem. Mol. Biol., 80, 137-148.
12. Strom,A. et al. (2004) Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc. Natl Acad. Sci. USA, 101, 1566-1571.
13. Sundar,S.N. et al. (2006) Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells. Mol. Endocrinol., 20, 3070-3082.
14. Paruthiyil,S. et al. (2004) Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res., 64, 423-428.
15. Ariazi,E.A. et al. (2006) Estrogen receptors as therapeutic targets in breast cancer. Curr. Top. Med. Chem., 6, 181-202.
16. Osborne,M.P. (1999) Chemoprevention of breast cancer. Surg. Clin. North Am., 79, 1207-1221.
17. Gielen,S.C. et al. (2005) Analysis of estrogen agonism and antagonism of tamoxifen, raloxifene, and ICI182780 in endometrial cancer cells: A putative role for the epidermal growth factor receptor ligand amphiregutin. J. Soc. Gynecol. Investig., 12, e55-e67.
18. Meshnick,S.R. (2003) Artemisinin and heme. Antimicrob. Agents Chemother., 47, 2712; author reply 2712-2713.
19. Paik,I.H. et al. (2006) Second generation, orally active, antimalarial, artemisinin-derived trioxane dimers with high stability, efficacy, and anti-cancer activity. J. Med. Chem., 49, 2731-2734.
20. Dell'Eva,R. et al. (2004) Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate. Biochem. Pharmacol., 68, 2359-2366.
21. Efferth,T. et al. (2004) Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron. Free Radic. Biol. Med., 37, 998-1009.
22. Nam,W. et al. (2007) Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells. Head Neck, 29, 335-340.
23. Berman,RA. et al. (1997) Artemisinin enhances heme-catalysed oxidation of lipid membranes. Free Radic. Biol. Med., 22, 1283-1288.
24. Efferth,T. et al. (2001) The anti-malarial artesunate is also active against cancer. Int. J. Oncol., 18, 767-773.
25. Lai,H. et al. (2006) Oral artemisinin prevents and delays the development of 7,12-dimethylbenz(a)anthracene (DMBA)-induced breast cancer in the rat. Cancer Lett., 231, 43-48.
26. Chan,M.M. et al. (2005) Gene expression profiling of NMU-induced rat mammary tumors: Cross species comparison with human breast cancer. Carcinogenesis, 26, 1343-1353.
27. de Cremoux,P. et al. (2002) Quantitation of estradiol receptors alpha and beta and progesterone receptors in human breast tumors by real-time reverse transcription-polymerase chain reaction. Correlation with protein assays. Biochem. Pharmacol., 64, 507-515.
28. Petz,L.N. et al. (2004) Differential regulation of the human progesterone receptor gene through an estrogen response element half site and Sp1 sites. J. Steroid Biochem. Mol. Biol., 88, 113-122.
29. Wiese,T.E. et al. (1992) Optimization of estrogen growth response in MCF-7 cells. In Vitro Cell. Dev. Biol., 28A, 595-602.
30. Long,X. et al. (2006) Fulvestram (ICI 182,780)-dependent interacting proteins mediate immobilization and degradation of estrogen receptor-alpha. J. Biol. Chem., 281, 9607-9615.
31. Madureira,P.A. et al. (2006) The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells. J. Biol. Chem., 281, 25167-25176.
32. Eeckhoute,J. et al. (2007) Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer. Cancer Res., 67, 6477-6483.
33. Chakrabarty,A. et al. (2007) Ets-2 and C/EBP-beta are important mediators of ovine trophoblast Kunitz domain protein-1 gene expression in trophoblast. BMC Mol. Biol., 8, 14.
34. Shimokawa,T. et al. (2003) C/EBP alpha and Ets protein family members regulate the human myeloid IgA Fc receptor (Fe alpha R, CD89) promoter. J. Immunol., 170, 2564-2572.
35. Park,J.S. et al. (2000) A role for both Ets and C/EBP transcription factors and mRNA stabilization in the MAPK-dependent increase in p21 (Cip-1/WAF1/mda6) protein levels in primary hepatocytes. Mol. Biol. Cell, 11, 2915-2932.
36. Lindberg,M.K. et al. (2003) Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a "ying yang", relationship between ERalpha and ERbeta. in mice. Mol. Endocrinol. 17, 203-208.
37. Rees,E.D. et al. (1968) Influence of five anti-cancer drugs on the induction and growth of experimental mammary cancers: Comparison with ovariectomy. Cancer, 21, 1029-1041.